CD274 and hepatocellular carcinoma: HCC patients with positive RECK and negative PD-L1 expression had the best prognosis and may not benefit from anti-angiogenic therapy and ICI treatment, while patients with negative RECK and positive PD-L1 expression had the worst prognosis and may be indicated for both anti-angiogenic therapy and ICI treatment.